Overview of Treatments for Spasticity and Dystonia
December 13, 2022
December 31, 2024
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Catalyst Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare .
This activity is supported by an educational grant from Allergan.
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit(s)™
- Nurses — 0.25 Contact Hours
- Nurse Practitioners — 0.25 Contact Hours (.25 hour(s) of pharmacology)
All other healthcare professionals completing this course will be issued a statement of participation.
This initiative is intended for US neurologists, physiatrists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, physical therapists, and occupational therapists.
In this activity, Dr. Yeva Fernandez will review the mechanisms of action, clinical utility, potential benefits, and risks of different medical management options for spasticity and dystonias. For additional activities and other information, please visit www.impact-smd.com/.
Upon completion of this activity, participants should be better able to:
- Review the mechanisms of efficacy and indications of treatment options for spasticity and dystonia
- Assess potential benefits and risks of different treatment options for spasticity and dystonia
Yeva M. Fernandez, MD
Clinical Assistant Professor
Hackensack Meridian School of Medicine
Hackensack Meridian Jersey Shore University Medical Center
Yeva Fernandez, MD has recently joined the Hackensack Meridian Medical Group team as a board-certified, fellowship-trained neurologist with a specialized focus in movement disorders. She attended Ross University School of Medicine for her medical degree and New York Medical College for her master’s degree. She completed her residency in neurology at Rutgers-Robert Wood Johnson University Hospital (RWJUH) in New Brunswick, New Jersey. She also completed a fellowship in movement disorders at Mount Sinai in New York. In addition to her fellowship training, Dr. Fernandez completed her postgraduate training at the National Institutes of Health Movement Disorders Clinic.
Prior to joining Hackensack Meridian Health, Dr. Fernandez was an assistant professor at Rutgers-Robert Wood Johnson Medical School. Her experience consists of research in Parkinson disease, as well as years of resident teaching positions at Rutgers-RWJUH and Mount Sinai School of Medicine. Dr. Fernandez is recognized as a member of the American Academy of Neurology, the Movement Disorders Society, and the International Neurotoxin Association.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit provided by AKH Inc., Advancing Knowledge in Healthcare
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
0.25 ANCC contact hours.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803.
This activity is approved for 0.25 contact hour(s) (which includes .25 hour(s) of pharmacology).
Disclosures of Conflicts of Interest
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Yeva M. Fernandez, MD, has disclosed no financial relationships.
Jessica F Marshall, PhD, Medical Writer, has no financial relationships to disclose.
Trish Brignoni, AKH Director of Operations, has disclosed no financial relationships.
Wendi Martin, AKH Continuing Education Coordinator, has disclosed no financial relationships.
AKH and Catalyst Medical Education, LLC Planners and Reviewers, have disclosed no financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
Instructions for Participation and Credit
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
If you have questions about this activity, please contact AKH Inc. at [email protected].